Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity. 2009

Hua Su, and Jennifer H Gunter, and Melissa de Vries, and Tim Connor, and Stephen Wanyonyi, and Felicity S Newell, and David Segal, and Juan Carlos Molero, and Ofer Reizes, and Johannes B Prins, and Louise J Hutley, and Ken Walder, and Jonathan P Whitehead
Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, Qld 4102, Australia.

We previously described a putative role for inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme in de novo guanine nucleotide biosynthesis, in lipid accumulation. Here we present data which demonstrate that IMPDH activity is required for differentiation of preadipocytes into mature, lipid-laden adipocytes and maintenance of adipose tissue mass. In 3T3-L1 preadipocytes inhibition of IMPDH with mycophenolic acid (MPA) reduced intracellular GTP levels by 60% (p<0.05) and blocked adipogenesis (p<0.05). Co-treatment with guanosine, a substrate in the salvage pathway of nucleotide biosynthesis, restored GTP levels and adipogenesis demonstrating the specificity of these effects. Treatment of diet-induced obese mice with mycophenolate mofetil (MMF), the prodrug of MPA, for 28 days did not affect food intake or lean body mass but reduced body fat content (by 36%, p=0.002) and adipocyte size (p=0.03) and number. These data suggest that inhibition of IMPDH may represent a novel strategy to reduce adipose tissue mass.

UI MeSH Term Description Entries
D007168 IMP Dehydrogenase An enzyme that catalyzes the dehydrogenation of inosine 5'-phosphate to xanthosine 5'-phosphate in the presence of NAD. EC 1.1.1.205. Inosinic Acid Dehydrogenase,Inosine-5-Monophosphate Dehydrogenase,Acid Dehydrogenase, Inosinic,Dehydrogenase, IMP,Dehydrogenase, Inosine-5-Monophosphate,Dehydrogenase, Inosinic Acid,Inosine 5 Monophosphate Dehydrogenase
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006151 Guanosine A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed)
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015431 Weight Loss Decrease in existing BODY WEIGHT. Weight Reduction,Loss, Weight,Losses, Weight,Reduction, Weight,Reductions, Weight,Weight Losses,Weight Reductions

Related Publications

Hua Su, and Jennifer H Gunter, and Melissa de Vries, and Tim Connor, and Stephen Wanyonyi, and Felicity S Newell, and David Segal, and Juan Carlos Molero, and Ofer Reizes, and Johannes B Prins, and Louise J Hutley, and Ken Walder, and Jonathan P Whitehead
February 2003, Bioorganic & medicinal chemistry letters,
Hua Su, and Jennifer H Gunter, and Melissa de Vries, and Tim Connor, and Stephen Wanyonyi, and Felicity S Newell, and David Segal, and Juan Carlos Molero, and Ofer Reizes, and Johannes B Prins, and Louise J Hutley, and Ken Walder, and Jonathan P Whitehead
November 1987, Biochimica et biophysica acta,
Hua Su, and Jennifer H Gunter, and Melissa de Vries, and Tim Connor, and Stephen Wanyonyi, and Felicity S Newell, and David Segal, and Juan Carlos Molero, and Ofer Reizes, and Johannes B Prins, and Louise J Hutley, and Ken Walder, and Jonathan P Whitehead
January 2009, Advances in enzymology and related areas of molecular biology,
Hua Su, and Jennifer H Gunter, and Melissa de Vries, and Tim Connor, and Stephen Wanyonyi, and Felicity S Newell, and David Segal, and Juan Carlos Molero, and Ofer Reizes, and Johannes B Prins, and Louise J Hutley, and Ken Walder, and Jonathan P Whitehead
May 1968, Endocrinology,
Hua Su, and Jennifer H Gunter, and Melissa de Vries, and Tim Connor, and Stephen Wanyonyi, and Felicity S Newell, and David Segal, and Juan Carlos Molero, and Ofer Reizes, and Johannes B Prins, and Louise J Hutley, and Ken Walder, and Jonathan P Whitehead
November 2002, Bioorganic & medicinal chemistry,
Hua Su, and Jennifer H Gunter, and Melissa de Vries, and Tim Connor, and Stephen Wanyonyi, and Felicity S Newell, and David Segal, and Juan Carlos Molero, and Ofer Reizes, and Johannes B Prins, and Louise J Hutley, and Ken Walder, and Jonathan P Whitehead
September 2020, International journal of molecular sciences,
Hua Su, and Jennifer H Gunter, and Melissa de Vries, and Tim Connor, and Stephen Wanyonyi, and Felicity S Newell, and David Segal, and Juan Carlos Molero, and Ofer Reizes, and Johannes B Prins, and Louise J Hutley, and Ken Walder, and Jonathan P Whitehead
November 1999, Biochemistry,
Hua Su, and Jennifer H Gunter, and Melissa de Vries, and Tim Connor, and Stephen Wanyonyi, and Felicity S Newell, and David Segal, and Juan Carlos Molero, and Ofer Reizes, and Johannes B Prins, and Louise J Hutley, and Ken Walder, and Jonathan P Whitehead
June 2007, Nature medicine,
Hua Su, and Jennifer H Gunter, and Melissa de Vries, and Tim Connor, and Stephen Wanyonyi, and Felicity S Newell, and David Segal, and Juan Carlos Molero, and Ofer Reizes, and Johannes B Prins, and Louise J Hutley, and Ken Walder, and Jonathan P Whitehead
February 1987, Blood,
Hua Su, and Jennifer H Gunter, and Melissa de Vries, and Tim Connor, and Stephen Wanyonyi, and Felicity S Newell, and David Segal, and Juan Carlos Molero, and Ofer Reizes, and Johannes B Prins, and Louise J Hutley, and Ken Walder, and Jonathan P Whitehead
August 2006, Journal of medicinal chemistry,
Copied contents to your clipboard!